As of 2026-06-01, the Fair Value of Ascentage Pharma Group International (6855.HK) is -19.19 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 39.24 HKD, the upside of Ascentage Pharma Group International is -148.89%.
With the market price of 39.24 HKD and our fair value calculation, Ascentage Pharma Group International (6855.HK) is not a good investment. Investing in 6855.HK stocks now will result in a potential loss of 148.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -782.42 | -882.92 | -925.64 | -405.43 | -1,242.77 | -847.84 |
| YoY growth | -15.47% | -12.84% | -4.84% | 56.20% | -206.53% | -36.70% |
| Market Cap (mil) | 14,649.08 |
| P/E | |
| Forward P/E |
| EPS | -3.33 |
| Avg earnings growth rate | -36.70% |
| TTM earnings | -1,242.77 |